SG Americas Securities LLC Acquires 1,159,250 Shares of Colgate-Palmolive Company $CL

SG Americas Securities LLC boosted its holdings in shares of Colgate-Palmolive Company (NYSE:CL) by 3,896.0% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,189,005 shares of the company’s stock after acquiring an additional 1,159,250 shares during the period. SG Americas Securities LLC owned 0.15% of Colgate-Palmolive worth $93,955,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also bought and sold shares of the business. S.A. Mason LLC increased its stake in shares of Colgate-Palmolive by 3.9% during the third quarter. S.A. Mason LLC now owns 3,499 shares of the company’s stock valued at $280,000 after purchasing an additional 130 shares in the last quarter. Security National Bank of Sioux City Iowa IA boosted its position in shares of Colgate-Palmolive by 0.8% in the 3rd quarter. Security National Bank of Sioux City Iowa IA now owns 16,241 shares of the company’s stock worth $1,298,000 after purchasing an additional 130 shares in the last quarter. Stratos Wealth Advisors LLC grew its stake in shares of Colgate-Palmolive by 4.5% in the 3rd quarter. Stratos Wealth Advisors LLC now owns 3,015 shares of the company’s stock worth $241,000 after buying an additional 130 shares during the last quarter. Chicago Partners Investment Group LLC grew its stake in shares of Colgate-Palmolive by 1.5% in the 3rd quarter. Chicago Partners Investment Group LLC now owns 9,387 shares of the company’s stock worth $724,000 after buying an additional 136 shares during the last quarter. Finally, Cary Street Partners Investment Advisory LLC increased its position in Colgate-Palmolive by 17.7% during the 2nd quarter. Cary Street Partners Investment Advisory LLC now owns 911 shares of the company’s stock valued at $83,000 after buying an additional 137 shares in the last quarter. Hedge funds and other institutional investors own 80.41% of the company’s stock.

Analysts Set New Price Targets

A number of research analysts have issued reports on CL shares. Wall Street Zen upgraded Colgate-Palmolive from a “hold” rating to a “buy” rating in a research note on Saturday. Bank of America raised their price target on Colgate-Palmolive from $90.00 to $100.00 and gave the company a “buy” rating in a report on Monday, February 2nd. Evercore lifted their price target on Colgate-Palmolive from $94.00 to $100.00 and gave the stock an “outperform” rating in a research report on Monday, February 2nd. Wells Fargo & Company upped their price target on shares of Colgate-Palmolive from $86.00 to $94.00 and gave the stock an “equal weight” rating in a research note on Sunday, February 1st. Finally, Deutsche Bank Aktiengesellschaft increased their price objective on shares of Colgate-Palmolive from $83.00 to $90.00 and gave the company a “hold” rating in a research report on Monday, February 2nd. Eleven analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $94.75.

Colgate-Palmolive Price Performance

NYSE CL opened at $85.00 on Tuesday. Colgate-Palmolive Company has a 52 week low of $74.54 and a 52 week high of $99.33. The firm has a market capitalization of $68.52 billion, a P/E ratio of 32.44, a PEG ratio of 3.81 and a beta of 0.28. The company has a quick ratio of 0.54, a current ratio of 0.83 and a debt-to-equity ratio of 18.82. The company has a 50-day moving average price of $91.07 and a 200-day moving average price of $83.37.

Colgate-Palmolive (NYSE:CL) last posted its quarterly earnings data on Friday, January 30th. The company reported $0.95 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.91 by $0.04. The company had revenue of $5.23 billion for the quarter, compared to the consensus estimate of $5.13 billion. Colgate-Palmolive had a net margin of 10.45% and a return on equity of 353.72%. The firm’s revenue was up 5.8% compared to the same quarter last year. During the same quarter last year, the firm posted $0.91 earnings per share. Equities research analysts anticipate that Colgate-Palmolive Company will post 3.75 earnings per share for the current year.

Colgate-Palmolive Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, May 15th. Stockholders of record on Monday, April 20th will be paid a dividend of $0.53 per share. The ex-dividend date is Monday, April 20th. This represents a $2.12 annualized dividend and a dividend yield of 2.5%. This is a boost from Colgate-Palmolive’s previous quarterly dividend of $0.52. Colgate-Palmolive’s dividend payout ratio is 79.39%.

Insider Buying and Selling at Colgate-Palmolive

In other news, COO Panagiotis Tsourapas sold 15,000 shares of the company’s stock in a transaction on Thursday, February 12th. The stock was sold at an average price of $97.81, for a total value of $1,467,150.00. Following the completion of the sale, the chief operating officer directly owned 10,415 shares in the company, valued at $1,018,691.15. This represents a 59.02% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this link. Also, insider Sally Massey sold 15,851 shares of the firm’s stock in a transaction on Thursday, February 5th. The stock was sold at an average price of $95.03, for a total value of $1,506,320.53. Following the completion of the transaction, the insider directly owned 13,751 shares in the company, valued at approximately $1,306,757.53. This represents a 53.55% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last 90 days, insiders sold 184,683 shares of company stock worth $17,486,693. 0.41% of the stock is currently owned by insiders.

Colgate-Palmolive Profile

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.